New analysis shows a larger increase in COVID deaths, and deaths from all causes, in the North of England compared to the South and indicates the efficacy of lockdown has differed across the UK.
The analysis released today by the Northern Health Science Alliance, in collaboration with the NIHR Applied Research Collaborations (ARCs) in the North East & North Cumbria and Greater Manchester, indicates that the lockdown decreased mortality rates much faster in London and South East than in the North East in particular.
That data maps ONS figures on COVID deaths, and deaths from all causes, across the main train lines in England to see how different urban and rural centres performed compared to the national average in the months of March, April and May. Mortality rates in London and the South decreased much faster between April and May than they did in the North. The three regions with the highest COVID mortality in May are all in the North: the North East, the North West, and Yorkshire and the Humber.
Although mortality rates peaked in all areas in April the month by month analysis suggest that the lock down decreased mortality much more effectively in London and the South East than in other parts of the UK which could have implications when looking at local lockdowns to manage further waves of the virus.
Dr Luke Munford of the University of Manchester said: “These data show that the trends in the North are decreasing much slower than the rest of the country. In May, the three worst hit regions were all Northern, whereas the three regions with the lowest COVID mortality rates were all Southern. All-cause mortality is also much higher in the North. We need to understand why this is; what is different in the North compared to the South?”
Professor Clare Bambra of Newcastle University said: “The pandemic is evolving differently across the North and the South of England. This needs to be taken into account when developing the next stages of our response. We cannot have centralised, one size fits all policies when different regions are at different stages of the pandemic.”
Health Inequalities lead for the Northern Health Science Alliance Hannah Davies said: “These figures add more weight to the negative relationship between health inequalities and COVID19 they also provide an argument to take a place-based approach to managing outbreaks in different areas.
“Closer investigation into the impact of lockdown measures in different areas of the country could potentially add intelligence to public health management of further waves of the virus.”
The NHSA is a partnership established by the leading Universities and NHS Hospital Trusts in the North of England to improve the health and wealth of the region by creating an internationally recognised life science and healthcare system. It links ten universities and ten research-intensive NHS Teaching Trusts with four Academic Health Science Networks (AHSNs covering a population of over 16 million).
The organisation brings together health research collaborations across the region, draws in international investment to the North and acts as a voice for its health research system.
The Applied Research Collaborations (ARCs) in the North East & North Cumbria and Greater Manchester are regional applied health research collaborations funded by the National Institute for Health Research (NIHR).
View and download the full ‘Analysis of COVID19 ONS Data March to May 2020’ here
Related News Articles
Open letter calls for local public health investment
NHSA supports call for investment in local public health at the Spending Review
Northern life sciences supercluster would bring £16.52bn a year to the UK’s economy
NHSA and NP11 publish 'A Northern Life Sciences Supercluster' report
North inequalities cost UK economy £7.3bn over first year of the pandemic
New NHSA report lays clear the devastating impact of the pandemic on people across the North of England.